1[1]San Miguel JF, Garcia-Sanz R, Gonzalez M, et al. DNA cell content studies in multiple myeloma[J]. Leuk Lymphoma, 1996, 23 (1-2): 33-41.
2[2]Tabernero D, San Miguel JF, Garcia Sanz M, et al. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes [J]. Am J Pathl, 1996,149(1): 153-161.
3[3]Smadja NV, Fruchart C, Isnard F, et al. Chromosomal analysis in multiple myeloma: cytogenetic evidence of two different diseases[J]. Leukemia, 1998,12(6) :960-969.
4[4]Zandecki M, Bemardi F, Genevieve F, et al. Involvement of peripheral blood cells in multiple myeloma: chromosome changes are the rule within circulating plasma cells but not within B lymphocytes[J]. Leukemia, 1997, 11(7): 1034-1039.
5[5]Gutierrez NC, Hemandez JM, Garcia JL, et al. Correlation between cytogenetic abnormalities and disease characteristics in multiple myeloma:monosomy of chromosome 13 and structural abnormalities of 11q are associated with a high percentage of S-phase plasma cells[J]. Haematologica, 2000,85 (11): 1146-1152.
6[6]Bergsagel PL, Chesi M, Nardini E, et al. Promiscuous translocation into immunoglonulin heavy chain switch regions in multiple myeloma [J].Proc Natl Acad Sci USA, 1996,93(24): 13931-13936.
7[7]Avet-Loiseau H, Facon T, Grosbois B, et al. Oncogenesis of multiple myeloma: 1432 and 13q chromosomal abnormalities are not randomly distributed,but correlate with natural history, immunological features,and clinical presentation[J]. Blood,2002,99(6): 2185-2191.
8[8]Schop RF, Jalal SM, Van Wier SA, et al. Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at the time of disease progression [J]. Cancer Genet Cytogenet,2002,132(1): 55-60.
9[9]Cigudosa JC, Rao PH, Calasanz MJ, et al. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization[J]. Blood, 1998,91 (8) :3007-3010.
10[10]Shimazaki C, Goto H, Araki S, et al. Overexpression of PRAD1/cyclin D1 in plasma cell leukemia with t(11; 14) (q13;q32) [J]. Int J Hematol, 1997,66(1): 111-115.
